all report title image

ROTAVIRUS VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Rotavirus Vaccine Market, By Vaccine Type (Monovalent Vaccines (e.g., Rotarix) and Pentavalent Vaccines (e.g., RotaTeq)), By Strength (1 mL Oral Suspension and 2 mL Oral Solution), By Dosing Regimen (2-dose and 3-dose), By Patient Age Group (Infants (2-6 months), Preterm Infants, and Older Infants/Children (7 months and above)), By End User (Pediatric Hospitals, Pediatric Clinics, Vaccination Centers, Community Health Centers, and Academic and Research Institutions), By Distribution Channel (Public (Government) Distribution, Private Distribution, and International Agencies (e.g., UNICEF, Gavi, WHO procurement)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 17 Mar, 2026
  • Code: CMI8586
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Rotavirus Vaccine Market, By Vaccine Type
      • Global Rotavirus Vaccine Market, By Strength
      • Global Rotavirus Vaccine Market, By Dosing Regimen
      • Global Rotavirus Vaccine Market, By Patient Age Group
      • Global Rotavirus Vaccine Market, By End User
      • Global Rotavirus Vaccine Market, By Distribution Channel
      • Global Rotavirus Vaccine Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Rotavirus Vaccine Market, By Vaccine Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monovalent Vaccines (e.g., Rotarix)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Pentavalent Vaccines (e.g., RotaTeq)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Rotavirus Vaccine Market, By Strength, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • 1 mL Oral Suspension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • 2 mL Oral Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Rotavirus Vaccine Market, By Dosing Regimen, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • 2-dose
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • 3-dose
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Rotavirus Vaccine Market, By Patient Age Group, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Infants (2-6 months)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Preterm Infants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Older Infants/Children (7 months and above)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Rotavirus Vaccine Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Pediatric Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Vaccination Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Community Health Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Academic and Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Rotavirus Vaccine Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Public (Government) Distribution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Private Distribution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • International Agencies (e.g., UNICEF, Gavi, WHO procurement)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Rotavirus Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosing Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About Us

*Browse 32 market data tables and 28 figures on ‘Rotavirus Vaccine Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.